CHARACTERIZATION OF DYSKINESIAS INDUCED BY L-DOPA IN MPTP-TREATED SQUIRREL-MONKEYS

被引:51
|
作者
BOYCE, S
RUPNIAK, NMJ
STEVENTON, MJ
IVERSEN, SD
机构
[1] Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, CM20 2QR, Essex, Terlings Park
关键词
Chorea; Dystonia; l-dopa; Parkinson's disease; Squirrel monkey;
D O I
10.1007/BF02245739
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intermittent treatment with l-dopa over a 2-year period induced abnormal involuntary movements in MPTP-treated squirrel monkeys. Dyskinesias included a choreic and dystonic component. Dose-response curves for chorea and dystonia revealed that the same dose of l-dopa (30 mg/kg) induced the highest score for both dyskinesias; however, the severity was much greater for chorea. Choreic movements were always most prevalent at the time of peak effect, whereas dystonia was apparent at the time of peak effect and at "end-of-dose", and was occasionally observed spontaneously. Our findings indicate that squirrel monkeys treated with MPTP develop l-dopa-induced dyskinesias which closely resemble those observed in Parkinson's disease. This species provides a valuable animal model to develop improved therapeutic agents. © 1990 Springer-Verlag.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [41] SYNERGISTIC INTERACTIONS BETWEEN COMT-/MAO-INHIBITORS AND L-DOPA IN MPTP-TREATED MICE
    FREDRIKSSON, A
    ARCHER, T
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1995, 102 (01) : 19 - 34
  • [42] Differential effects of ropinirole, bromocriptine and L-DOPA on striatal preprodynorphin mrna expression in the MPTP-treated marmoset
    Tel, BC
    Cannizzaro, C
    Pearce, RKB
    Rose, S
    Jenner, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128
  • [43] Comparison of repeated treatment with L-DOPA, pergolide and apomorphine on dyskinesia induction in MPTP-treated common marmosets
    Maratos, E
    Jackson, MJ
    Pearce, RKB
    Jenner, P
    Marsden, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 : U3 - U3
  • [44] Effects of repeated treatment with combinations of L-DOPA and ropinirole on dyskinesia induction in MPTP-treated common marmosets
    Maratos, E
    Smith, L
    Jackson, MJ
    Pearce, RKB
    Jenner, P
    Marsden, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U145 - U145
  • [45] THE COMPETITIVE NMDA ANTAGONIST CGP40.116 ENHANCES L-DOPA RESPONSE IN MPTP-TREATED MARMOSETS
    WULLNER, U
    KUPSCH, A
    ARNOLD, G
    RENNER, P
    SCHEID, C
    SCHEID, R
    OERTEL, W
    KLOCKGETHER, T
    NEUROPHARMACOLOGY, 1992, 31 (07) : 713 - 715
  • [46] Effects of repeated treatment with L-DOPA, bromocriptine and ropinirole in drug naive MPTP-treated common marmosets
    Pearce, RKB
    Banerji, T
    Jenner, P
    Marsden, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 : P37 - P37
  • [47] Inducing dyskinesia in MPTP-treated common marmosets: The effects of repeated treatment with combinations of L-dopa and ropinirole
    Maratos, E
    Smith, L
    Jackson, MJ
    Pearce, RKB
    Jenner, P
    Marsden, CD
    NEUROLOGY, 1998, 50 (04) : A135 - A135
  • [48] The effect of pardoprunox (SLV308) treatment on L-dopa induced dyskinesia in MPTP-treated common marmosets, a chronic study
    Jackson, M. J.
    Tayarani-Binazir, K.
    Rose, S.
    McCreary, A. C.
    Jenner, P. G.
    MOVEMENT DISORDERS, 2008, 23 (01) : S306 - S306
  • [49] MIRTAZAPINE - AN UNDERRATED DRUG FOR L-DOPA INDUCED DYSKINESIAS
    Verma, O.
    Singh, H.
    Sawal, N.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E70 - E70
  • [50] BEHAVIORAL AND BIOCHEMICAL-COMPARISON OF REPEATED ADMINISTRATION OF BROMOCRIPTINE AND L-DOPA IN 6-OHDA LESIONED RATS AND IN MPTP-TREATED PARKINSONIAN MONKEYS
    ROUILLARD, C
    BEDARD, PJ
    BOUCHER, R
    DIPAOLO, T
    FALARDEAU, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (02) : 179 - 180